Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, December 2003, p. 3989-3993, Vol. 47, No. 12
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.12.3989-3993.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Prevalence of Extended-Spectrum ß-Lactamase-Producing Enterobacter cloacae in the Asia-Pacific Region: Results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001
J. M. Bell,1* J. D. Turnidge,1 R. N. Jones,2 and the SENTRY Asia-Pacific Participants
Microbiology and Infectious Diseases Department, Women's and Children's Hospital, Adelaide, Australia,1
The JONES Group/JMI Laboratories, North Liberty, Iowa, and The Tufts University School of Medicine, Boston, Massachusetts2
Received 9 January 2003/
Returned for modification 17 May 2003/
Accepted 30 August 2003
Enterobacter
cloacae strains from hospitalized patients with a range of
infections were collected by 17 laboratories in the Asia-Pacific region
and South Africa. Isolates for which ceftriaxone MICs were above 1
µg/ml and/or ceftazidime MICs were above 2 µg/ml, as
well as 46 strains for which ceftriaxone and/or ceftazidime MICs were
at or below these values, were screened for levels of extended-spectrum
ß-lactamase (ESBL) production through the use of broth
microdilution for the detection of clavulanate enhancement of the
activity of ceftriaxone, ceftazidime, and cefepime. Of the isolates
examined, ceftriaxone and/or ceftazidime had elevated MICs for
44%, of which 36% were ESBL positive. ESBL-positive
strains were commonly susceptible to piperacillin-tazobactam and more
frequently resistant to several other antimicrobials studied. A
cefepime MIC above 0.25 µg/ml had the highest sensitivity
(100%) and specificity (74%) for predicting the presence
of an
ESBL.
* Corresponding author. Mailing address: Microbiology and Infectious Diseases Department, Women's and Children's Hospital, 72 King William Rd., North Adelaide, SA, 5006 Australia. Phone: 61-8-8204-6359. Fax: 61-8-8204-6051. E-mail:
bellj{at}mail.wch.sa.gov.au.
SENTRY Asia-Pacific participants are listed in Acknowledgments.
Antimicrobial Agents and Chemotherapy, December 2003, p. 3989-3993, Vol. 47, No. 12
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.12.3989-3993.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Duerink, D. O., Lestari, E. S., Hadi, U., Nagelkerke, N. J. D., Severin, J. A., Verbrugh, H. A., Keuter, M., Gyssens, I. C., van den Broek, P. J., on behalf of the study group 'Antimicrobial Resist,
(2007). Determinants of carriage of resistant Escherichia coli in the Indonesian population inside and outside hospitals. J Antimicrob Chemother
60: 377-384
[Abstract]
[Full Text]
-
Manzur, A., Tubau, F., Pujol, M., Calatayud, L., Dominguez, M. A., Pena, C., Sora, M., Gudiol, F., Ariza, J.
(2007). Nosocomial Outbreak Due to Extended-Spectrum-Beta-Lactamase- Producing Enterobacter cloacae in a Cardiothoracic Intensive Care Unit. J. Clin. Microbiol.
45: 2365-2369
[Abstract]
[Full Text]
-
Bell, J. M., Chitsaz, M., Turnidge, J. D., Barton, M., Walters, L. J., Jones, R. N.
(2007). Prevalence and Significance of a Negative Extended-Spectrum {beta}-Lactamase (ESBL) Confirmation Test Result after a Positive ESBL Screening Test Result for Isolates of Escherichia coli and Klebsiella pneumoniae: Results from the SENTRY Asia-Pacific Surveillance Program. J. Clin. Microbiol.
45: 1478-1482
[Abstract]
[Full Text]
-
Sidjabat, H. E., Hanson, N. D., Smith-Moland, E., Bell, J. M., Gibson, J. S., Filippich, L. J., Trott, D. J.
(2007). Identification of plasmid-mediated extended-spectrum and AmpC {beta}-lactamases in Enterobacter spp. isolated from dogs. J Med Microbiol
56: 426-434
[Abstract]
[Full Text]
-
Szabo, D., Bonomo, R. A., Silveira, F., Pasculle, A. W., Baxter, C., Linden, P. K., Hujer, A. M., Hujer, K. M., Deeley, K., Paterson, D. L.
(2005). SHV-Type Extended-Spectrum Beta-Lactamase Production Is Associated with Reduced Cefepime Susceptibility in Enterobacter cloacae. J. Clin. Microbiol.
43: 5058-5064
[Abstract]
[Full Text]
-
Weiss, W. J., Petersen, P. J., Murphy, T. M., Tardio, L., Yang, Y., Bradford, P. A., Venkatesan, A. M., Abe, T., Isoda, T., Mihira, A., Ushirogochi, H., Takasake, T., Projan, S., O'Connell, J., Mansour, T. S.
(2004). In Vitro and In Vivo Activities of Novel 6-Methylidene Penems as {beta}-Lactamase Inhibitors. Antimicrob. Agents Chemother.
48: 4589-4596
[Abstract]
[Full Text]